Mara is the Vice President and Head of Global Regulatory Affairs for Sionna. She is an accomplished drug development professional with substantial experience in regulatory affairs and global R&D strategy. Prior to Sionna, she was the Head of Regulatory Affairs for Apellis Pharmaceuticals, where she led the team to deliver the company’s first global marketing authorizations.
She previously held senior positions at Shire Pharmaceuticals in both Regulatory Affairs and R&D Business Operations, where she focused on due diligence assessments for in-licensed assets across therapeutic areas. In her earlier roles at Amicus Therapeutics and Cato Research, she advanced multiple rare disease programs through early and mid-stage development. Mara holds a master’s degree in biochemistry from Duke University and earned Regulatory Affairs Certification.